• Medical Translation
    • Medical Translation Services
      • COVID-19 Emergency Response Team
      • CTD/eCTD Submission
      • Linguistic Validation
      • eLearning & Training
      • Back Translation
      • Creative Communication
      • Terminology Management
      • Software Localization
      • Medical Document Translation Services
      • Linguistic Testing
      • Machine Translation Post-Editing
      • In-Country Review
      • Multilingual Desktop Publishing (DTP)
      • Technical Translation
      • Pharmacovigilance
      • Clinical Studies
      • Patient Recruitment
  • Industries
    • Medical Devices
    • Hospital Translation
    • Chemical Translations
    • In-Vitro Diagnostic Devices
    • Pharmaceuticals
    • Biotechnology
    • Health Science Legal Translation Services
    • Government, NGO & Non-Profit
  • Interpretation
    • Interpretation Services
      • CDE Pre IND/NDA Meeting
      • Medical Conferences
      • Phone Interpretation
      • Video Interpretation
  • Executive Management
  • HealthFirst 100
    • About HealthFirst 100
      • Health
      • Articles
      • News
      • White Papers & Case Studies
  • CSOFT International
  • English
    • 简体中文
    • Español
  • CSOFT International
  • News & Events
  • Careers
  • Contact
  • English
    • 简体中文 (Chinese (Simplified))
    • Español (Spanish)
  • CSOFT International
  • CSOFT International
  • CSOFT International
  • CSOFT International
CSOFT Health Sciences
  • Medical Translation
    • Medical Translation Services
      • COVID-19 Emergency Response Team
      • CTD/eCTD Submission
      • Linguistic Validation
      • eLearning & Training
      • Back Translation
      • Creative Communication
      • Terminology Management
      • Software Localization
      • Medical Document Translation Services
      • Linguistic Testing
      • Machine Translation Post-Editing
      • In-Country Review
      • Multilingual Desktop Publishing (DTP)
      • Technical Translation
      • Pharmacovigilance
      • Clinical Studies
      • Patient Recruitment
  • Industries
    • Medical Devices
    • Hospital Translation
    • Chemical Translations
    • In-Vitro Diagnostic Devices
    • Pharmaceuticals
    • Biotechnology
    • Health Science Legal Translation Services
    • Government, NGO & Non-Profit
  • Interpretation
    • Interpretation Services
      • CDE Pre IND/NDA Meeting
      • Medical Conferences
      • Phone Interpretation
      • Video Interpretation
  • Executive Management
  • HealthFirst 100
    • About HealthFirst 100
      • Health
      • Articles
      • News
      • White Papers & Case Studies
  • CSOFT International
  • English
    • 简体中文
    • Español
Select Page
OSE Immunotherapeutics Strengthens IPR for Anti-interleukin-7 Receptor (IL-7R) Antagonist OSE-127/S95011

OSE Immunotherapeutics Strengthens IPR for Anti-interleukin-7 Receptor (IL-7R) Antagonist OSE-127/S95011

Feb 17, 2021 | News, Regulatory

OSE Immunotherapeutics, a clinical stage biotechnology company, announced today (2/17) that it was granted a patent by the European Patent Office (EPO) for its anti-interleukin-7 receptor (IL-7R) antagonist OSE-127/S95011. The patent, set to last until 2037, covers...
Orphazyme Receives Priority Review by FDA for Treatment of Niemann-Pick Disease Type C

Orphazyme Receives Priority Review by FDA for Treatment of Niemann-Pick Disease Type C

Sep 16, 2020 | News, Regulatory

Orphazyme, a biotech company based in Denmark, announced today (9/16) that the FDA has accepted its New Drug Application (NDA) for treatment of Niemann-Pick disease Type C. The genetic disease is both rare as well as fatal, with no currently approved...
Lowering Prescription Drug Prices for Affordability and Accessibility for US Citizens

Lowering Prescription Drug Prices for Affordability and Accessibility for US Citizens

Aug 21, 2020 | Clinical Trials, FDA, Globalization, Healthcare, Pharmaceuticals

One of the biggest areas of concern in the pharmaceutical industry, particularly in the United States, is the high costs of new treatments or drug therapies for patients. The recent initiatives from regulatory agencies like the Food and Drug Administration (FDA) to...
Pfizer Signs Multiyear Agreement to Make Gilead’s Remdesivir

Pfizer Signs Multiyear Agreement to Make Gilead’s Remdesivir

Aug 7, 2020 | News, Regulatory

Pfizer announced today (8/7) that it has signed a multiyear agreement for Gilead’s remdesivir, a treatment for COVID-19. With Gilead aiming to produce enough remdesivir to treat more than 2 million patients by the end of the year, and agreeing to send...
Key Factors Driving Medical Writing Outsourcing Strategy – II

Key Factors Driving Medical Writing Outsourcing Strategy – II

Jun 4, 2020 | Medical Writing

CSOFT Health Sciences SVP Dr. Nimita Limaye joins us once again to continue her interview on Key Factors Driving Medical Writing Outsourcing Strategy. This time, she focuses on the importance of alignment in terms of business operations, business models and cultural...

Recent Posts

  • FDA Approves Targeted Treatment for Duchenne Muscular Dystrophy
  • FDA Partially Rescinds Two Supplemental Biologics License Applications
  • Sinopharm Unit and CanSinoBio apply for Public Use Approval of COVID-19 Vaccine in China
  • FDA Makes Recommendations for COVID-19 Variants
  • FDA Clears Brainlab Loop-X Mobile Imaging Robot and Cirq Robotic Alignment Module

Topics

  • CFDA
  • Classification System
  • Clinical Trials
  • e-Labeling
  • e-Learning
  • EMA
  • Events
  • FDA
  • Globalization
  • Health
  • Healthcare
  • In-Country Review
  • Innovation
  • Interpretation
  • Language Service Provider
  • Linguistic Validation
  • Machine Translation
  • Medical Translation
  • Medical Writing
  • Mistranslations
  • Mobile Translation
  • News
  • Pharmaceuticals
  • Quality
  • Regulatory
  • Resources
  • Social Media
  • Special stories
  • Terminology
  • Transcreation
  • Website Translation
  • Translation
  • CTD/eCTD Submission
  • Clinical Studies
  • Clinical Trials
  • Linguistic Validation
  • Back Translation
  • Medical Writing
  • eLearning & Training
  • Creative Communication
  • Terminology Management
  • Interpretation
  • CDE Pre IND/NDA Meeting
  • Medical Conferences
  • Over the Phone
  • Medical Writing
  • Regulatory Writing
  • Medico-Marketing
  • Publication Writing
  • Medical Writing Safety Writing
  • Lay Summaries
  • Informed Consent Form Translation
  • Patient Safety Narratives
  • Advisory Boards
  • Summaries of Safety
  • Asia Regulatory Services
  • Asia Market Access
  • Asia Regulatory Strategy
  • Clinical Trials in Asia
Environmental Responsibility and Sustainability at CSOFT
    ISO 9001 and ISO 13485 Certified © 2021 CSOFT International, Inc.    Terms of Use    Privacy Policy